find below the March Newsletter. If you would like to post any articles
that will be of interest to SV members or information about your company,
please email it to us.
develops and markets advanced detection & imaging systems
for medical applications, planning to close second round in a few weeks.
Spectros recently received FDA approval and seeking $1MM bridge
to drive efficacy studies in second and third markets. Funds will be
applied to completing multi-center economic trials, AAA product launch,
clinical feasibility trials and building a sales and marketing team.
A few months ago Silicom members invested in the company and are investing
in this round as well. For the one page overview please click
here. If you are interested in learning more about this investment
opportunity, please send email to firstname.lastname@example.org
Companies under Due Diligence
offers technology and products for the wireless audio market.
The company claims they had over $7M in sales in 04 and predict $12M
in 05. Major industry leaders that use their technology include iRiver,
Delphi (XM Radio), Kensington (iPod), and Mito corp. Aerielle stated
that they are under negotiations with Sandisk, Philips, and Creative-Labs.
For the executive summary pls click
here. If you are interested in this investment opportunity please
developed new technology for improved metrology in wafer inspection.
There was an initial interest from some members, primarily from those
familiar with the technology. A few members in the group have been working
to identify the potential for the technology and drafted a term sheet
to be submitted to the company. For the one page overview of NanoOr
here. If you would like further information please contact nanoOr@silicomventures.com
a state-of-the-art skydiving wind tunnel designed for the general
public, received funding from a few Silicom Ventures members and from
other sources. The company is looking for additional $400K to close
a $4M round A. They are offering preferred units to investors in a franchise
like model to minimize the risk to investors and still offer excellent
If you are interested in learning more about this investment opportunity
please contact email@example.com
Research, the CEO Amit Goswamy reported that the
company has had a positive discussion with the FDA. Based on that, Chakshu
has initiated pre-clinical studies which are scheduled for completion
in May, 2005. They will form the basis of the Investigational New Drug
(IND) application in June 2005. Assuming a satisfactory outcome, the
FDA has also recommended that Chakshu plan for a combined Phase 1 and
2 human trial. These trials are expected to commence in 4Q/2005 and
will be jointly conducted in USA and India. The company is looking
to raise $10M round. For more information please contact us.
Past Presenting Companies
Circumnav Networks, provide optimized yet cost-effective
roadway route information based on dynamic traffic condition, made some
great progress since they participated in Silicom Ventures annual party
last October. The company have their first wi-fi access point deployed
out on highway 101 in Santa Clara in conjunction with Caltrans. They
also have a launch program established with one of the largest consumer
electronics retailers in the country for initial distribution. They
have also secured the next tranche of funding from Skymoon Ventures.
To read more, please visit www.circumnavnetworks.com
Inc. sells an advanced Enterprise Single-Sign-On software,
allowing employees to log onto their secure systems (websites, applications,
terminals) from anywhere without typing passwords. MetaPass partners
with strong authentication device companies (USB tokens, fingerprint
readers, smart cards...) and has over 200 corporate customers. The company
is currently raising funding to keep up with its growth. For more information
about MetaPass please visit www.metapass.com
Welcome to three new Advisory Board Members
Breiner is a principal in New Ventures West, a sole proprietorship
used as his personal high tech business incubator. He received a B.S.,
M.S., and Ph.D., all in Geophysics, from Stanford University. For more
about Sheldon please click
here. On February 24th Sheldon was a keynote speaker at Michelle
Rose's house and shared with us his adventures as the Indiana Jones
of Silicon Valley. For the article please click
Sokoloff is currently the Chairman of Investment Screening
of Tenex Medical, Inc., a pure life science angel network. Dr. Sokoloff
is a Venture Partner at a boutique firm, Shalon Ventures, with the purpose
of creating new life science companies meeting unmet needs in large
markets. Dr. Sokoloff was one of 25 people in the country selected for
the Penn State-Jefferson Medical College 5-Year Program in 1964, receiving
his BS and his MD degrees and he has an MBA from UC Irvine. Click
here for more about Dr. Sokoloff.
Geller is a Professor of Anesthesia and Surgery at Stanford
University School of Medicine. Professor Geller is board certified in
Anesthesiology (residency at the Massachusetts General hospital in Boston).
He is a former Professor and Chairman of the Department of Anesthesia
and Intensive Care at the Tel Aviv Medical Center. Dr. Geller holds
a BSEE from Wayne State University, MSEE (Bio-Med) and MD from Northwestern
University in Chicago.
More about Dr. Geller.
Your feedback is welcome. For articles and any information that might
interest the group to be posted in the next newsletter, Please contact:
Ventures is not a broker nor investment advisor and does not provide
investment advice, and this newsletter should not be relied on as such
nor is it a substitute for investment advice. The information provided
in this newsletter is based on sources believed to be reliable and in
good faith, it is not guaranteed either as to accuracy or completeness,
and independent verification should be sought before making any decisions.